Study of pyruvate kinase activity in human astrocytomas - Alanine-inhibition test revisted

Neurology India

Volumn 57, Issue 2, 2009, Pages 140-142

  Javalkar, V K ^a   Vinod, K Y ^a   Sharada, S ^a   Chandramouli, B A ^a   Subhash, M N ^a   Kolluri, V R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Alanine inhibition; Astrocytomas; Human brain; Isozymes; Pyruvate kinase

Indexed keywords

ALANINE; PYRUVATE KINASE;

ARTICLE; ASTROCYTOMA; CANCER GRADING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; SPECTROPHOTOMETRY;

ALANINE; ANALYSIS OF VARIANCE; ASTROCYTOMA; BIOPSY; BRAIN NEOPLASMS; HUMANS; PYRUVATE KINASE; SEVERITY OF ILLNESS INDEX;

EID: 67249096150     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.51281     Document Type: Article

References (14)

1. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008;452:230-3.
2. van Veelen CW, Verbiest H, van Ketel BA, van der Vlist MJ, Vlug AM, Rijksen G, Staal GE. L-alpha alanine inhibition of pyruvate kinase from tumors of the human central nervous system. Cancer Res 1979;39:4263-9.
3. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer 1988;62:2152-65.
4. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin Phenol reagent. J Biol Chem 1951;193:265-75.
5. nd ed. New York, NY: Academic press, Inc; 1974. p. 509-10.
6. Sherwin AL, LeBlanc FE, McCann WP. Altered LDH isoenzymes in brain tumors. Arch Neurol 1968;18:311-5.
7. Subhash MN, Shankar SK, Rao BSS, Deshpande DH. Tissue lactate dehydrogenase isoenzyme activity in the differential diagnosis of tumors and other space occupying lesions of brain. Curr Sci 1981;50:868-70.
8. Townes PL. Electrophoresis of human pyruvate kinase. Lancet 1968;1:920-1.
9. van Veelen CW, Verbiest H, Zülch KJ, van Ketel B, van der Vlist MJ, Vlug AM, et al. Pyruvate kinase in human brain tumors. Its significance in the treatment of gliomas. Acta Neurochir (Wien) 1982;61:145-59.
10. van Veelen CW, Verbiest H, Vlug AM, Rijksen G, Staal GE. Isozymes of pyruvate kinase from human brain, meningiomas, and malignant gliomas. Cancer Res 1978;38:4681-7.
11. Cardenas JM, Dyson RD. Mammalian pyruvate kinase hybrid isozymes: Tissue distribution and physiological significance. J Exp Zool 1978;204:361-7.
12. Marie J, Kahn A, Boivin P. Pyruvate kinase isozymes in man. I. M type isozymes in adult and foetal tissues, electrofocusing and immunological studies. Hum Genet 28;31:35-45.
13. van Veelen CW, Rijksen G, Van Ketel BA, Staal GE. The pyruvate kinase isoenzyme shift in human gliomas: A potential marker in the treatment of gliomas. Br J Neurosurg 1988;2:257-63.
14. Mostert HW, de Both NJ, Rhijnsburger EH, Mackay WM, van den Berge JH, Stefanko SZ. Pyruvate kinase inhibition in the diagnosis of gliomas with an intermediate degree of malignancy. Acta Neuropathol 1986;70:296-301.